Table 1 Participants descriptive statistics

Gender

Female

8

15

Male

5

13

Cancer diagnosis

Breast cancer

8

4

Chorio carcinoma

5

Kaposi’s Sarcoma

2

1

Ovarian Carcinoma

2

Cervical Carcinoma

2

Oesophageal carcinoma

2

Colorectal carcinoma

1

1

Pancreatic carcinoma

1

Small cell lung carcinoma

1

1

Nasopahrgeal carcinoma

1

Sinonaso carcinoma

2

1

Osteosarcoma

2

Rhabdosarcoma

1

Fibrosarcoma

4

Chemotherapy

Cyclophosphamide, Adriamycin

5 fluoro-uracil (CAF)

8

4

Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide Vincristine (EMACO)

5

Bleomycin and Vinicristine (BV)

2

1

5 fluoro-uracil, Leucovorin and Oxaliplatin (FolFox-6)

1

Cisplatin and Etoposide

1

Gemicitabine, Bleomycin, Etoposide and Cisplatin

1

Cisplatin and Etoposide

1

Cisplatin and 5 Fluoro Uracil

2

Cisplatin and Paclitaxel

3

Doxorubicin, Vincristine, Cytarabine and Dounorubicin

1

Bleomycin, Vinicristine and Paclitaxel

2

Ifosphamide and Doxorubicin

1

Bleomycin, Etoposide and Cisplatin

1

Cisplatin and Doxorubicin

2

Oxaliplatin and Capecitabine

1

Vincristine,Adriamycin and Dacabazine

1

Gemicitabine and Docetaxel

1

Cyclophosphamide,Adriamycin, Vincristine and Prednisolone (CHOP)

1

Paclitaxel

2